Search
for
Sort by
Research 391–420 of 778
- Treatments for alopecia areata: a network meta-analysis
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- 3-Deoxysappanchalcone Promotes Proliferation of Human Hair Follicle Dermal Papilla Cells and Hair Growth in C57BL/6 Mice by Modulating WNT/β-Catenin and STAT Signaling
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Interleukin-15 is a hair follicle immune privilege guardian
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Gut microbiome, metabolome and alopecia areata
- 689 Cell-type-specific nascent transcriptomics through PRECISE-seq reveal molecular principles of tissue dynamics
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Extracellular Vesicles for Androgenetic Alopecia: Current Evidence, Mechanisms, and Clinical Prospects
- Role of Aire and Notch4 Allelic Mutations in Alopecia Areata in C3H/HeJ Mice
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Prostaglandins: Key players in immunomodulation of the nervous system